MORGAN STANLEY - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$57,407,000
+24.5%
2,470,147
-14.7%
0.02%
+23.1%
Q1 2018$46,117,000
-63.1%
2,896,777
-51.9%
0.01%
-61.8%
Q4 2017$125,140,000
+150.4%
6,022,182
+72.7%
0.03%
+126.7%
Q3 2017$49,969,000
+21.8%
3,487,039
+47.0%
0.02%
+25.0%
Q2 2017$41,030,000
-33.0%
2,371,724
-57.3%
0.01%
+33.3%
Q1 2017$61,262,000
+12.6%
5,554,126
+48.2%
0.01%0.0%
Q4 2016$54,416,000
-62.9%
3,747,614
-37.2%
0.01%
-82.0%
Q3 2016$146,508,000
+316.4%
5,967,745
+241.6%
0.05%
+284.6%
Q2 2016$35,186,000
-34.2%
1,747,172
-14.1%
0.01%
-38.1%
Q1 2016$53,506,000
-28.7%
2,034,477
+175.6%
0.02%
-22.2%
Q4 2015$75,035,000
-86.5%
738,166
-76.3%
0.03%
-86.8%
Q3 2015$555,642,000
-21.8%
3,114,928
-2.7%
0.20%
-16.7%
Q2 2015$710,920,000
+10.7%
3,200,176
-1.1%
0.25%
+3.8%
Q1 2015$642,459,000
+28.4%
3,234,610
-7.5%
0.24%
+29.5%
Q4 2014$500,191,000
+0.7%
3,495,150
-7.6%
0.18%
-4.2%
Q3 2014$496,486,000
+2.4%
3,784,193
-1.6%
0.19%
+0.5%
Q2 2014$484,866,000
-15.6%
3,844,475
-11.7%
0.19%
-20.8%
Q1 2014$574,151,000
+31.3%
4,355,243
+17.0%
0.24%
+29.0%
Q4 2013$437,130,000
+13.8%
3,723,429
+1.1%
0.19%
+2.2%
Q3 2013$384,165,000
+12.0%
3,682,215
-7.6%
0.18%
+5.2%
Q2 2013$343,019,0003,984,8780.17%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q4 2014
NameSharesValueWeighting ↓
ACCIPITER CAPITAL MANAGEMENT, LLC 2,106,379$55,398,00031.67%
Claren Road Asset Management, LLC 80,000$2,820,00024.27%
Okumus Fund Management Ltd. 3,722,464$97,901,00015.82%
Wingspan Investment Management, LP 852,900$22,431,00012.66%
FARLEY CAPITAL L.P. 307,458$8,086,00011.46%
Chou Associates Management 976,843$25,725,0008.35%
Wingspan Investment Management, LP 550,700$14,483,0008.17%
HAP Trading, LLC 4,043,900$109,610,0008.00%
LeVasseur Capital Partners LLC 128,269$3,373,0006.97%
Pershing Square Capital Management 21,591,122$567,847,0006.41%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders